erdafitinib,azacitidine
janssen
['erdafitinib', 'urothelial', 'urothelial carcinoma', 'erda', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'aza ', ' uc,(-ucsd),(-ucsf),']
presence of fgfr2/3 mutation/fusion was associated with lower or and shorter pfs in pts with auc treated with first line ici
#gu23 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni